ADMA Biologics ADMA Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Business Acquisitions Pro Forma Revenue by Business | ||||||
| ADMA Bio Manufacturing | $113.74M0.0% | —— | —— | —— | $113.72M— | |
| Plasma Collection Centers | $716K-31.8% | —— | —— | —— | $1.05M— | |
| Revenue by Product | ||||||
| ASCENIV | $97.49M+27.7% | —— | —— | —— | $76.33M+27.4% | |
| BIVIGAM | $15.42M-54.0% | —— | —— | —— | $33.51M-5.8% | |
| Intermediates And Other | $833K-78.5% | —— | —— | —— | $3.87M-54.4% | |
| Revenue by Geography | ||||||
| Non Us | $1.07M-73.8% | $1.79M-37.6% | $246K-95.2% | $0-100% | $4.07M+4.8% | |
| US | $113.43M+2.4% | $137.38M+19.8% | $133.98M+16.8% | $121.98M+18.7% | $110.73M+42.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ADMA Biologics break its business down?
- ADMA Biologics (ADMA) reports business acquisitions pro forma revenue by business across 2 parts — ADMA Bio Manufacturing and Plasma Collection Centers. Each is extracted from the segment footnotes and tracked over time.
- Where does ADMA Biologics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ADMA Biologics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
